fura-2 has been researched along with thromboxane b2 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimori, T; Harada, K; Katayama, K; Kogushi, M; Saeki, T; Yoshimura, T | 1 |
| Chou, TC; Ding, YA; Hsu, LY; Yen, MH | 1 |
| Fujinishi, A; Kuroiwa, A; Nakashima, Y; Ohba, C; Takahara, K | 1 |
| Chen, TL; Chen, YW; Chou, DS; Hsiao, G; Lee, LW; Lin, CH; Luk, HN; Sheu, JR | 1 |
| Chang, Y; Chen, TL; Fong, TH; Hsiao, G; Liu, CM; Lu, MS; Shen, MY; Sheu, JR | 1 |
| Bigalke, B; Borst, O; Faggio, C; Gawaz, M; Lang, F; Laufer, S; Münzer, P; Russo, A; Schmid, E; Walker, B | 1 |
6 other study(ies) available for fura-2 and thromboxane b2
| Article | Year |
|---|---|
A new anti-platelet drug, E5510, has multiple suppressive sites during receptor-mediated signal transduction in human platelets.
Topics: Arachidonic Acid; Arachidonic Acids; Binding Sites; Blood Platelets; Calcium; Carbon Radioisotopes; Cyclic AMP; Fatty Acids, Monounsaturated; Fura-2; Humans; Male; Phospholipases A; Phospholipases A2; Phosphoric Diester Hydrolases; Phosphorylation; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Receptors, Cell Surface; Signal Transduction; Thrombin; Thromboxane B2 | 1991 |
The inhibitory effect of 2-thienyl 2'-hydroxyphenyl ketone (C85) on platelet thromboxane formation.
Topics: Adenosine Triphosphate; Animals; Blood Platelets; Calcium; Dinoprostone; Fura-2; Humans; Ketones; Mice; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Thiophenes; Thromboxane B2 | 1996 |
Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Antithrombin III; beta-Thromboglobulin; Blood Coagulation; Blood Platelets; Blood Pressure; Calcium; Calcium Channel Blockers; Coronary Angiography; Coronary Disease; Cytosol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Fibrinolytic Agents; Fluorescent Dyes; Fura-2; Heart Rate; Humans; Male; Nisoldipine; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Factor 4; Thromboxane B2; Tissue Plasminogen Activator; Vasodilator Agents | 1997 |
Mechanisms involved in the antiplatelet activity of midazolam in human platelets.
Topics: Blood Platelets; Calcium; Collagen; Flow Cytometry; Fluorescent Dyes; Fura-2; Humans; Hypnotics and Sedatives; In Vitro Techniques; Inositol Phosphates; L-Lactate Dehydrogenase; Midazolam; Phospholipids; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Kinase C; Signal Transduction; Thromboxane B2 | 2002 |
Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies.
Topics: Animals; Blood Platelets; Capillaries; Cell Membrane; Cyclic AMP; Cyclic GMP; Electrophoresis, Capillary; Fluorescein; Fluorescent Dyes; Fura-2; Humans; Immunohistochemistry; In Vitro Techniques; Matrix Metalloproteinase 9; Mice; Nitrates; Phospholipids; Platelet Activation; Platelet Aggregation; Protein Kinase C; Splanchnic Circulation; Thromboxane B2 | 2004 |
Skepinone-L, a novel potent and highly selective inhibitor of p38 MAP kinase, effectively impairs platelet activation and thrombus formation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Blood Platelets; Calcium; Carrier Proteins; Dibenzocycloheptenes; Fura-2; HSP27 Heat-Shock Proteins; Humans; p38 Mitogen-Activated Protein Kinases; Peptides; Phospholipases A2; Phosphorylation; Platelet Activation; Platelet Aggregation; Protein Kinase Inhibitors; Shear Strength; Thrombin; Thrombosis; Thromboxane B2 | 2013 |